Evidence map›Paper›PMID 38541013›Full record

ArticleJournal of personalized medicine2024

Non-Cardiac Amyloidosis Findings Are Not Increased in African American Carriers of

Scott Kaniper, Dorret Lynch, Samuel M Owens, Larisa Ibric, Yuliya Vabishchevich, Nana Nyantakyi, Fan Chun, Lionel Sam, Carly Fabrizio, Eman Hamad and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Scott KaniperLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Dorret LynchLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Samuel M OwensLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0009-0001-2338-7928
Larisa IbricLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Yuliya VabishchevichLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Nana NyantakyiLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Fan ChunLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Lionel SamLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Carly FabrizioLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.
Eman HamadLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0003-1513-0310
Glenn S GerhardLewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA.ORCID 0000-0001-6276-0337

Funding

Genentech G-76756Pfizer (United States) 57279519
6 · The paper itself

Abstract

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive systemic disease involving the extracellular deposition of misfolded transthyretin protein. The hereditary subtype is caused by mutations in the transthyretin (

Indexed as

African American ancestryamyloidcardiomyopathyhereditary ATTR-CMtransthyretin

Identifiers

PMID38541013
PMCPMC10971554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.